Pharmafile Logo
Pharmafocus logo
Advanced Search

Eli Lilly

Showing 15 posts of 218 posts found.

novo_flag

Novo diabetes drug outperforms Lilly rival at Phase 3

August 17, 2017
Research and Development Eli Lilly, Novo Nordisk, diabetes, life sciences, medicine, pharma, pharmaceutical, type 2 diabetes

Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling …

News

Lilly snaps up autoimmune drug in $400m biotech partnership

July 25, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, Nektar, aceutical, biotech, drugs, healthcare, phar, pharma

Eli Lilly is to enter a partnership with Nektar Therapeutics to tap into the biotech’s new autoimmune disease therapy as …

News

Eli Lilly arthritis drug outperforms Humira and receives NICE backing

June 30, 2017
Medical Communications, Research and Development, Sales and Marketing Eli Lilly, NICE, Olumiant, rheumatoid arthritis

Eli Lilly’s rheumatoid arthritis (RA) drug Olumiant (baricitinib) has been deemed cost-effective by NICE and has been recommended to be …

News
fda2outsideweb

FDA fast-tracks Pfizer and Lilly’s chronic pain drug

June 15, 2017
Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer

Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …

News

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017
Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …

News
sanofi_hq_reception_close

EMA’s CHMP recommends Sanofi’s Humalog biosimilar

May 22, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi

Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …

News
headquarters_2_web

Lilly’s migraine drug succeeds in Phase 3 trials

May 15, 2017
Research and Development, Sales and Marketing Eli Lilly, migraines

Eli Lilly announced the successful results of three Phase 3 trials examining the benefits of its drug, galcanezumab, in patients …

News

Lilly promises $850 million investment in message to White House

March 27, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, President trump, lilly

Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly …

News
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017
Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

News
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017
Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …

News
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …

News
donald_trump_september_3_2015

Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices

January 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump

President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …

News
insulin-syringe-1972843_960_720

Price-fixing class action lawsuit levelled at three major insulin producers

January 31, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing

A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …

News
u_of_liverpool

Major pharma firms join Liverpool Uni in £14m pharmacovigilance project

January 30, 2017
Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance

The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …

News
headquarters_2_web

Lilly brings migraine drug home with $960m acquisition

January 19, 2017
Sales and Marketing CoLucid Pharmaceuticals, Eli Lilly

Eli Lilly has announced it is to shell out $960 million to snatch up CoLucid Pharmaceuticals and specifically its migraine …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025